NCT07046117View on ClinicalTrials.gov

Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

August 1, 2028

Conditions
Asthma BronchialeChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
DRUG

Tezepelumab

injection with Tezepelumab every 4 weeks

Trial Locations (1)

A-1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER